Posttransplant Lymphoproliferative Disorders in Cardiac Transplant Patients

By Fatio R.   Sutsch G.   Mayer K.   Follath F.   Corti R.   Gallino A.   Kiowski W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1118-1120

Elsevier

Access to resources Recommend Favorite

Rabbit antithymocyte globulin induction immunosuppression in heart transplantation

By Chien N.C.   Lin F.L.   Chou N.K.   Hsu R.B.   Wang S.S.   Chu S.H.   Ko W.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2380-2382

Elsevier

Access to resources Recommend Favorite

Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy

By Crespo-Leiro M.G.   Paniagua M.J.   Mosquera I.   Tabuyo T.   De la Fuente L.   Bouzas B.   Rodriguez J.A.   Hermida L.F.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 113-114

Elsevier

Access to resources Recommend Favorite

Risks and Benefits of Withdrawing Cyclosporine From the Long-Term Immunosuppression Regimen of Heart and Heart-Lung Transplant Recipients

By Walker S.   Habib S.   Thompson D.   Khaghani A.   Yacoub M.   Banner N.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1149-1151

Elsevier

Access to resources Recommend Favorite

Autologous Lymphokine-Activated Killer Cell Therapy of Lymphoproliferative Disorders Arising in Organ Transplant Recipients

By Nalesnik M.A.   Rao A.S.   Zeevi A.   Fung J.J.   Pham S.   Furukawa H.   Gritsch A.   Klein G.   Starzl T.E.  

Transplantation Proceedings, Vol. 29, Iss. 3, 1997-05 ,pp. : 1905-1906

Elsevier

Access to resources Recommend Favorite